Current:Home > Contact-usBig Pharma’s Johnson & Johnson under investigation in South Africa over ‘excessive’ drug prices-LoTradeCoin
Big Pharma’s Johnson & Johnson under investigation in South Africa over ‘excessive’ drug prices
View Date:2024-12-24 00:00:18
CAPE TOWN, South Africa (AP) — U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country’s antitrust regulator said Friday.
J&J’s Belgium-based subsidiary Janssen Pharmaceuticals is also under investigation, South Africa’s Competition Commission said.
The commission, which regulates business practices, said it opened the investigation this week based on information that the companies “may have engaged in exclusionary practices and excessive pricing” of the tuberculosis drug bedaquiline, which is sold under the brand name Sirturo.
The Competition Commission declined to give further details of its investigation, but health advocacy groups in South Africa say the country is being charged more than twice as much for bedaquiline than other middle- and low-income countries.
Bedaquiline was approved in 2012 and is used to treat drug-resistant TB. It is desperately-needed by South Africa, where the infectious disease is the leading cause of death, killing more than 50,000 people in 2021. South Africa has more than 7 million people living with HIV, more than any other country in the world. The World Health Organization says that nearly one-third of deaths among people who have HIV/AIDS are due to tuberculosis.
Globally, TB cases increased in 2021 for the first time in years, according to the WHO.
J&J has previously faced calls to drop its prices for bedaquiline and said last month that it would provide a six-month course of the drug for one patient through the Stop TB Partnerships Global Drug Facility at a cost of $130.
The South African government purchases its bedaquiline directly from J&J and Janssen and not through the Stop TB facility and was paying around $280 for a six-month course for a patient, according to Professor Norbert Ndjeka, who leads the national department of health’s TB control and management.
Ndjeka said that South Africa had recently concluded a new two-year deal with J&J for bedaquiline at a slightly higher price than $280 per course, according to a report on the News24 website.
The Competition Commission said it was confirming the investigation due to heightened media interest, but would not respond to requests for comment or more information about the probe.
It comes a week after a health advocacy group released details of South Africa’s COVID-19 vaccine purchase contracts with numerous pharmaceutical companies, including J&J and U.S.-based Pfizer. They were obtained after the group, the Health Justice Intiative, won a freedom of information case in court.
The group says the contracts show J&J charged South Africa 15% more per vaccine dose than it charged the much richer European Union. Pfizer charged South Africa more than 30% more per vaccine than it charged the African Union, even as South Africa struggled to acquire doses while having more COVID-19 infections than anywhere else on the continent.
In the contract, South Africa was required to pay Pfizer $40 million in advance for doses, with only $20 million refundable if the vaccines weren’t delivered, the Health Justice Initiative said. J&J also required a non-refundable downpayment of $27.5 million.
Pfizer reported record revenues of $100.3 billion in 2022. J&J made $94.9 billion in sales last year.
___
AP Africa news: https://apnews.com/hub/africa
veryGood! (77)
Related
- Disney x Lululemon Limited-Edition Collection: Shop Before It Sells Out
- The Trump-DeSantis rivalry grows more personal and crude as the GOP candidates head to Florida
- Duane Keith Davis, charged with murder in Tupac Shakur's 1996 death, pleads not guilty in Las Vegas
- Baltimore couple plans to move up retirement after winning $100,000 from Powerball
- Gerry Faust, former Notre Dame football coach, dies at 89
- Man who blamed cancer on Monsanto weedkiller awarded $332 million
- House passes GOP-backed $14.3 billion Israel aid bill despite Biden veto threat
- Oregon must get criminal defendants attorneys within 7 days or release them from jail, judge says
- Brianna LaPaglia Reacts to Rumors Dave Portnoy Paid Her $10 Million for a Zach Bryan Tell-All
- How much you pay to buy or sell a home may be about to change. Here's what you need to know
Ranking
- Monument erected in Tulsa for victims of 1921 Race Massacre
- Jeff Bezos to leave Seattle for Miami
- LL Cool J and The Roots remix 'Mama Said Knock You Out' for NBA In-Season Tournament
- Lebanon’s militant Hezbollah leader threatens escalation with Israel as its war with Hamas rages on
- Dogecoin soars after Trump's Elon Musk announcement: What to know about the cryptocurrency
- Lancôme Deal Alert: Score a $588 Value Holiday Beauty Box for $79
- Jessica Simpson celebrates 6-year sobriety journey: 'I didn't respect my own power'
- Texas Rangers and their fans celebrate World Series title with parade in Arlington
Recommendation
-
Crews battle 'rapid spread' conditions against Jennings Creek fire in Northeast
-
Lack of affordable housing in Los Angeles’ Venice Beach neighborhood inspires activism and art
-
Neighborhood kids find invasive giant lizard lurking under woman's porch in Georgia
-
Next level: Unmanned U.S. Navy boat fires weapons in Middle East for first time
-
Footage shows Oklahoma officer throwing 70-year-old to the ground after traffic ticket
-
Belarus sentences independent newspaper editor to 4 years in prison
-
Former Detroit-area officer indicted on civil rights crime for punching Black man
-
Trump, other Republicans call for travel restrictions, sparking new 'Muslim ban' fears